MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic disease.

Shalini MoningiAtish D ChoudhuryNeil E MartinPaul L NguyenAnthony V D'AmicoDaniel N CagneyJonathan E Leeman

Published in: World journal of urology (2023)

Prostate SMART was found to be well tolerated and all patients had local control of disease within the prostate at the time of last follow-up. Prostate SMART may represent a low-risk and well-tolerated approach for delivering prostate-directed radiotherapy for patients with limited metastatic disease.

Keyphrases

prostate cancer
radical prostatectomy
benign prostatic hyperplasia
small cell lung cancer
ejection fraction
end stage renal disease
early stage
newly diagnosed
magnetic resonance imaging
computed tomography
locally advanced